DNLI
Price
$14.10
Change
-$0.39 (-2.69%)
Updated
Jun 27 closing price
Capitalization
2.05B
31 days until earnings call
IOVA
Price
$1.69
Change
-$0.09 (-5.06%)
Updated
Jun 27 closing price
Capitalization
564.35M
38 days until earnings call
Interact to see
Advertisement

DNLI vs IOVA

Header iconDNLI vs IOVA Comparison
Open Charts DNLI vs IOVABanner chart's image
Denali Therapeutics
Price$14.10
Change-$0.39 (-2.69%)
Volume$4.08M
Capitalization2.05B
Iovance Biotherapeutics
Price$1.69
Change-$0.09 (-5.06%)
Volume$17.53M
Capitalization564.35M
DNLI vs IOVA Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. IOVA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and IOVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DNLI: $14.10 vs. IOVA: $1.69)
Brand notoriety: DNLI and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 276% vs. IOVA: 125%
Market capitalization -- DNLI: $2.05B vs. IOVA: $564.35M
DNLI [@Biotechnology] is valued at $2.05B. IOVA’s [@Biotechnology] market capitalization is $564.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IOVA is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 2 TA indicator(s) are bullish while IOVA’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 2 bullish, 7 bearish.
  • IOVA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +1.51% price change this week, while IOVA (@Biotechnology) price change was -17.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

IOVA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.05B) has a higher market cap than IOVA($564M). DNLI YTD gains are higher at: -30.815 vs. IOVA (-77.162). IOVA has higher annual earnings (EBITDA): -354.01M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. IOVA (360M). DNLI has less debt than IOVA: DNLI (48.6M) vs IOVA (53.7M). IOVA has higher revenues than DNLI: IOVA (213M) vs DNLI (0).
DNLIIOVADNLI / IOVA
Capitalization2.05B564M363%
EBITDA-505.16M-354.01M143%
Gain YTD-30.815-77.16240%
P/E RatioN/AN/A-
Revenue0213M-
Total Cash818M360M227%
Total Debt48.6M53.7M91%
FUNDAMENTALS RATINGS
DNLI vs IOVA: Fundamental Ratings
DNLI
IOVA
OUTLOOK RATING
1..100
5078
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
6394
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (23) in the Biotechnology industry is significantly better than the same rating for DNLI (93). This means that IOVA’s stock grew significantly faster than DNLI’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DNLI (100). This means that IOVA’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (94) in the Biotechnology industry is in the same range as IOVA (97). This means that DNLI’s stock grew similarly to IOVA’s over the last 12 months.

DNLI's Price Growth Rating (63) in the Biotechnology industry is in the same range as IOVA (94). This means that DNLI’s stock grew similarly to IOVA’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as IOVA (100). This means that DNLI’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIIOVA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZSIX12.270.12
+0.99%
Lazard International Equity Select Instl
VQNPX65.960.42
+0.64%
Vanguard Growth & Income Inv
STSEX2536.802.41
+0.10%
BlackRock Exchange BlackRock
PDRDX11.77-0.01
-0.08%
Principal Diversified Real Asset Instl
FFGIX19.53-0.17
-0.86%
Fidelity Advisor Global Commodity Stk I

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-5.06%
PLX - IOVA
50%
Loosely correlated
+6.21%
ROIV - IOVA
44%
Loosely correlated
-1.81%
DNLI - IOVA
44%
Loosely correlated
-2.69%
CRSP - IOVA
43%
Loosely correlated
N/A
IMVT - IOVA
42%
Loosely correlated
-1.77%
More